These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30235762)

  • 1. First familial limb-girdle muscular dystrophy 2L in China: Clinical, imaging, pathological, and genetic features.
    Hu B; Xiong L; Zhou Y; Lu X; Xiong Q; Liu Q; Qi X; Ding W
    Medicine (Baltimore); 2018 Sep; 97(38):e12506. PubMed ID: 30235762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy.
    Hicks D; Sarkozy A; Muelas N; Köehler K; Huebner A; Hudson G; Chinnery PF; Barresi R; Eagle M; Polvikoski T; Bailey G; Miller J; Radunovic A; Hughes PJ; Roberts R; Krause S; Walter MC; Laval SH; Straub V; Lochmüller H; Bushby K
    Brain; 2011 Jan; 134(Pt 1):171-182. PubMed ID: 21186264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Japanese male with a novel ANO5 mutation with minimal muscle weakness and muscle pain till his late fifties.
    Kadoya M; Ogata K; Suzuki M; Honma Y; Momma K; Yatabe K; Tamura T; Kaida K; Miyata N; Nishino I; Nonaka I; Kawai M
    Neuromuscul Disord; 2017 May; 27(5):477-480. PubMed ID: 28214267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-onset limb-girdle muscular dystrophy-2L in a female athlete.
    Blackburn PR; Selcen D; Jackson JL; Guthrie KJ; Cousin MA; Boczek NJ; Clift KE; Klee EW; Dimberg EL; Atwal PS
    Muscle Nerve; 2017 May; 55(5):E19-E21. PubMed ID: 27862037
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparing clinical data and muscle imaging of DYSF and ANO5 related muscular dystrophies.
    Ten Dam L; van der Kooi AJ; Rövekamp F; Linssen WH; de Visser M
    Neuromuscul Disord; 2014 Dec; 24(12):1097-102. PubMed ID: 25176504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic Spectrum of Myopathies with Recessive Anoctamin-5 Mutations.
    Vázquez J; Lefeuvre C; Escobar RE; Luna Angulo AB; Miranda Duarte A; Delia Hernandez A; Brisset M; Carlier RY; Leturcq F; Durand-Canard MC; Nicolas G; Laforet P; Malfatti E
    J Neuromuscul Dis; 2020; 7(4):443-451. PubMed ID: 32925086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and characterisation of anoctamin 5 mutations in a cohort of Italian limb-girdle muscular dystrophy patients.
    Magri F; Del Bo R; D'Angelo MG; Sciacco M; Gandossini S; Govoni A; Napoli L; Ciscato P; Fortunato F; Brighina E; Bonato S; Bordoni A; Lucchini V; Corti S; Moggio M; Bresolin N; Comi GP
    Neuromuscul Disord; 2012 Nov; 22(11):934-43. PubMed ID: 22742934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Mutation in Anoctamin 5 Gene Causing Limb-Girdle Muscular Dystrophy 2L.
    Peddareddygari LR; Oberoi K; Baisre-De Leon A; Grewal RP
    J Clin Neuromuscul Dis; 2018 Jun; 19(4):228-231. PubMed ID: 29794579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anoctamin 5 Knockout Mouse Model Recapitulates LGMD2L Muscle Pathology and Offers Insight Into in vivo Functional Deficits.
    Thiruvengadam G; Sreetama SC; Charton K; Hogarth M; Novak JS; Suel-Petat L; Chandra G; Allard B; Richard I; Jaiswal JK
    J Neuromuscul Dis; 2021; 8(s2):S243-S255. PubMed ID: 34633328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal-dominant distal myopathy with a myotilin S55F mutation: sorting out the phenotype.
    Berciano J; Gallardo E; Domínguez-Perles R; Gallardo E; García A; García-Barredo R; Combarros O; Infante J; Illa I
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):205-8. PubMed ID: 17698502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic characterization of limb girdle muscular dystrophy R7 telethonin-related patients from three unrelated Chinese families.
    Chen H; Xu G; Lin F; Jin M; Cai N; Qiu L; Ye Z; Wang L; Lin M; Wang N
    Neuromuscul Disord; 2020 Feb; 30(2):137-143. PubMed ID: 32005491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical spectrum and gene mutations in a Chinese cohort with anoctaminopathy.
    Cai S; Gao M; Xi J; Liu Z; Yue D; Wu H; Bi H; Li J; Liang Z; Zhao C; Udd B; Luo S; Lu J
    Neuromuscul Disord; 2019 Aug; 29(8):628-633. PubMed ID: 31350120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel ANO5 mutations causing hyper-CK-emia, limb girdle muscular weakness and Miyoshi type of muscular dystrophy.
    Schessl J; Kress W; Schoser B
    Muscle Nerve; 2012 May; 45(5):740-2. PubMed ID: 22499103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANO5 mutations in the Dutch limb girdle muscular dystrophy population.
    van der Kooi AJ; Ten Dam L; Frankhuizen WS; Straathof CS; van Doorn PA; de Visser M; Ginjaar IB
    Neuromuscul Disord; 2013 Jun; 23(6):456-60. PubMed ID: 23607914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANO5 mutations in the Polish limb girdle muscular dystrophy patients: Effects on the protein structure.
    Jarmula A; Łusakowska A; Fichna JP; Topolewska M; Macias A; Johnson K; Töpf A; Straub V; Rosiak E; Szczepaniak K; Dunin-Horkawicz S; Maruszak A; Kaminska AM; Redowicz MJ
    Sci Rep; 2019 Aug; 9(1):11533. PubMed ID: 31395899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limb girdle muscular dystrophy type 2L presenting as necrotizing myopathy.
    Schneider I; Stoltenburg G; Deschauer M; Winterholler M; Hanisch F
    Acta Myol; 2014 May; 33(1):19-21. PubMed ID: 24843231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the Molecular Basis of the Dystrophic Process in Limb-Girdle Muscular Dystrophy LGMD-R12 by Differential Gene Expression Profiles in Diseased and Healthy Muscles.
    Depuydt CE; Goosens V; Janky R; D'Hondt A; De Bleecker JL; Noppe N; Derveaux S; Thal DR; Claeys KG
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective membrane fusion and repair in Anoctamin5-deficient muscular dystrophy.
    Griffin DA; Johnson RW; Whitlock JM; Pozsgai ER; Heller KN; Grose WE; Arnold WD; Sahenk Z; Hartzell HC; Rodino-Klapac LR
    Hum Mol Genet; 2016 May; 25(10):1900-1911. PubMed ID: 26911675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anoctamin-5 related muscle disease: clinical and genetic findings in a large European cohort.
    de Bruyn A; Montagnese F; Holm-Yildiz S; Scharff Poulsen N; Stojkovic T; Behin A; Palmio J; Jokela M; De Bleecker JL; de Visser M; van der Kooi AJ; Ten Dam L; Domínguez González C; Maggi L; Gallone A; Kostera-Pruszczyk A; Macias A; Łusakowska A; Nedkova V; Olive M; Álvarez-Velasco R; Wanschitz J; Paradas C; Mavillard F; Querin G; Fernández-Eulate G; Quinlivan R; Walter MC; Depuydt CE; Udd B; Vissing J; Schoser B; Claeys KG
    Brain; 2023 Sep; 146(9):3800-3815. PubMed ID: 36913258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel ANO5 splicing variant in a LGMD2L patient leads to production of a truncated aggregation-prone Ano5 peptide.
    Xu J; Xu L; Lau YS; Gao Y; Moore SA; Han R
    J Pathol Clin Res; 2018 Apr; 4(2):135-145. PubMed ID: 29665321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.